Gastrointestinal disorders in Parkinson's disease: Prevalence and health outcomes in a US claims database

Journal of Parkinson's Disease

Volumn 1, Issue 1, 2011, Pages 65-74

  Makaroff, Lydia ^a   Gunn, Angus ^a   Gervasoni, Christophe ^b   Richy, Florent ^a,c  

^a UCB PHARMA   (Belgium)

^b Chaussée de Louvain ^*  (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

gastrointestinal diseases; health care economics and organizations; outcome assessment (health care); Parkinson disease

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; ATAXIA; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FALLING; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; INFANT; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSEXUAL DISORDER; SLEEP DISORDER; UNITED STATES; URINE INCONTINENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DATABASES, FACTUAL; FEMALE; GASTROINTESTINAL DISEASES; HEALTH CARE COSTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; UNITED STATES; YOUNG ADULT;

EID: 79958233594     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-2011-001     Document Type: Article

References (20)

1. Parkinson J (2002) An essay on the shaking palsy (Reprinted). Journal of Neuropsychiatry and Clinical Neurosciences, 14, 223-236.
2. Rao SS, Hofmann LA, & Shakil A (2006) Parkinson's disease: diagnosis and treatment. American Family Physician, 74, 2046-2056.
3. Guttman M, Slaughter PM, Theriault ME, Dedoer DP, & Naylor CD (2003) Burden of parkinsonism: a populationbased study. Movement Disorders, 18, 313-319.
4. Chaudhuri KR, Healy DG, & Schapira AHV (2006) Nonmotor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurology, 5, 235-245. (Pubitemid 43238347)
5. Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurology, 2, 107-116. (Pubitemid 37443331)
6. Kaye J, Gage H, Kimber A, StoreyL, & Trend P (2006) Excess burden of constipation in Parkinson's disease: a pilot study. Movement Disorders, 21, 1270-1273. (Pubitemid 44336628)
7. Verbaan D, Marinus J,Visser M, van Rooden SM, Stiggelbout AM, & van Hilten JJ (2007) Patient-reported autonomic symptoms in Parkinson disease. Neurology, 69, 333-341. (Pubitemid 47205659)
8. Antonini A, Tolosa E, Mizuno Y, Yamamoto M, & Poewe WH (2009) A reassessment of risks and benefits of dopamine agonists in Parkinson's disease. Lancet Neurology, 8, 929-937.
9. Goole J, AmighiK(2009) Levodopa delivery systems for the treatment of Parkinson's disease: an overview. International Journal of Pharmaceutics, 380, 1-15.
10. Melamed E, Zoldan J, Galili-Mosberg R, Ziv I, & Djaldetti R (1999) Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa. Journal of Neural Transmission-Supplement, 173-183. (Pubitemid 29242878)
11. Brixner D (2006) Assessment of the prevalence and costs of osteoporosis treatment options in a real-world setting. American Journal of Managed Care, 12, S191-S198. (Pubitemid 43764989)
12. Lau HS, de Boer A, Beuning KS, & Porsius A (1997) Validation of pharmacy records in drug exposure assessment. Journal of Clinical Epidemiology, 50, 619-625. (Pubitemid 27270212)
13. Deyo RA, Cherkin DC, & Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology, 45, 613-619.
14. Parsons LS (2001) Reducing bias in a propensity-score matched-pair sample using greedy matching techniques. Proceedings of the 26th annual SAS® users group international conference, 214-226.
15. Edwards LL, Pfeiffer RF, Quigley EMM, Hofman R, & Balluff M (1991) Gastrointestinal symptoms in Parkinson's disease. Movement Disorders, 6, 151-156.
16. Guttman M, Slaughter PM, Theriault ME, Deboer DP, & Naylor CD (2001) Parkinsonism in ontario-increased mortality compared with controls in a large cohort study. Neurology, 57, 2278-2282. (Pubitemid 34019205)
17. Guttman M, Slaughter PM, Theriault ME, Deboer DP, & Naylor CD (2002) Parkinsonism in ontario: physician utilization. Canadian Journal of Neurological Sciences, 29, 221-226. (Pubitemid 34966316)
18. Noyes K, Liu HS, Li Y, Holloway R, & Dick AW (2006) Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries. Movement Disorders, 21, 362-372.
19. Muller T, Erdmann C, Bremen D, Schmidt WE, Muhlack S, Woitalla D, & Goetze O (2006) Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients. Clinical Neuropharmacology, 29, 61-67. (Pubitemid 44357153)
20. Djaldetti R, Baron J, Ziv I, & Melamed E (1996) Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology, 46, 1051-1054. (Pubitemid 26134650)